Outcome of case finding among relatives of patients with known heterozygous familial
- 16 December 2000
- Vol. 321 (7275) , 1497
- https://doi.org/10.1136/bmj.321.7275.1497
Abstract
Objectives: To assess the feasibility of detecting new cases of heterozygous familial hypercholesterolaemia by using a nurse led genetic register. Design: Case finding among relatives of patients with familial hypercholesterolaemia. Setting: Two lipid clinics in central and south Manchester. Subjects: 259 (137 men and 122 women) probands and 285 first degree relatives. Results: Of the 200 first degree relatives tested, 121 (60%) had inherited familial hypercholesterolaemia. The newly diagnosed patients were younger than the probands and were generally detected before they had clinically overt atherosclerosis. Concentrations of serum cholesterol were, respectively, 8.4 (1.7 SD) mmol/l and 8.1 (1.9 SD) mmol/l in affected men and women and 5.6 (1.0 SD) mmol/l and 5.6 (1.1 SD) mmol/l in unaffected men and women. Screening for risk factors as recommended in recent guidelines for coronary heart disease prevention would have failed to identify most of the affected relatives in whom hypertension, diabetes mellitus, cigarette smoking, and obesity were uncommon. Conclusions: By performing cholesterol tests on 200 relatives, 121 new patients with familial hypercholesterolaemia were discovered. Because 1 in 500 people in the UK are affected by this condition, to detect a similar number by population screening over 60 000 tests would be required, and only a few of these patients would have been detected had cholesterol testing been restricted to those with other risk factors for coronary heart disease. A case exists for organising a genetic register approach, linking lipid clinics nationally.Keywords
This publication has 18 references indexed in Scilit:
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Genetic testing for familial hypercholesterolaemia: practical and ethical issuesQJM: An International Journal of Medicine, 1997
- Is knowing your cholesterol number harmful?Journal of Clinical Epidemiology, 1994
- Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medicationsThe American Journal of Cardiology, 1993
- Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in UtahThe American Journal of Cardiology, 1993
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemiaAtherosclerosis, 1991
- Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Family similarities in the age at coronary death in familial hypercholesterolaemia.BMJ, 1977